{"tool_name":"pi","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"pi","home":"http://bioconductor.org/packages/release/bioc/html/Pi.html","license":"GPL-3.0","summary":"Genomic-led target prioritisation system, with the focus on leveraging human genetic data to prioritize potential drug targets at the gene, pathway and network level. The long-term goal is to use such information to enhance early-stage target validation. Based on evidence of disease association from genome-wide association studies, this prioritisation system can generate evidence to support identification of the specific modulated genes that are responsible for the genetic association signal.","addition_date":"2017-01-17T14:56:34Z","last_update_date":"2024-11-25T15:28:12.621892Z","tool_type":["Command-line tool","Library"],"version":["1.0.0"],"collections":["BioConductor"]},"bioschemas":{"name":"Pi","home":"https://bio.tools/pi","license":"GPL-3.0","version":"1.0.0","summary":"Genomic-led target prioritisation system, with the focus on leveraging human genetic data to prioritize potential drug targets at the gene, pathway and network level. The long-term goal is to use such information to enhance early-stage target validation. Based on evidence of disease association from genome-wide association studies, this prioritisation system can generate evidence to support identification of the specific modulated genes that are responsible for the genetic association signal.","tool_type":"sc:SoftwareApplication"}}}